tiprankstipranks
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
US Market

BridgeBio Pharma (BBIO) Income Statement

Compare
1,153 Followers

BridgeBio Pharma Income Statement

Last quarter (Q3 2024), BridgeBio Pharma's total revenue was $2.73M, a decrease of -33.22% from the same quarter last year. In Q3, BridgeBio Pharma's net income was $-162.04M. See BridgeBio Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 221.90M$ 9.30M$ 77.65M$ 69.72M$ 8.25M
Gross Profit
$ 218.02M$ 6.86M$ 74.21M$ 66.60M$ 5.16M
Operating Expenses
$ 811.00M$ 614.23M$ 546.09M$ 646.35M$ 482.73M
Depreciation and Amortization
$ 0.00$ 6.49M$ 6.77M$ 5.84M$ 3.09M
EBITDA
$ -592.97M$ -565.47M$ -397.44M$ -533.83M$ -465.75M
Operating Income
$ -592.97M$ -607.37M$ -471.87M$ -579.75M$ -474.48M
Other Income/Expenses
$ 50.78M$ -45.88M$ 27.55M$ -9.82M$ -31.01M
Pretax Income
$ -542.19M$ -653.25M$ -484.65M$ -586.45M$ -505.49M
Net Income
$ -535.76M$ -643.20M$ -493.96M$ -639.30M$ -483.93M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.88$ -3.95$ -3.35$ -4.43$ -4.10
Diluted EPS
$ -2.88$ -3.95$ -3.35$ -4.43$ -4.10
Weighted Average Shares Outstanding
186.08M 162.79M 147.47M 144.36M 118.00M
Weighted Average Shares Outstanding (Diluted)
186.08M 162.79M 147.47M 144.36M 118.00M
Currency in USD

BridgeBio Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis